ProShares - Ultra Nasdaq Biotechnology
ETF- Fund size (USD)
- $102.23M
- Expense Ratio
- 1.17%
- Yield (12 mo)
- 0.10%
- Holdings
- 274
Your view on BIB
ProShares - Ultra Nasdaq Biotechnology
ETFProShares- Fund size (USD)
- $102.23M
- Expense Ratio
- 1.17%
- Yield (12 mo)
- 0.10%
- Holdings
- 274
Overview
What the fund invests in, who runs it, and what it costs.
ProShares - Ultra Nasdaq Biotechnology (BIB) is an Equity fund from ProShares, listed since 2010, with $102.2M in assets under management, a 1.17% expense ratio and a NAV of $116.17 USD.
Overview for ProShares - Ultra Nasdaq Biotechnology
- Fund Type
- ETF
- Fund Issuer
- ProShares
- Asset Class
- Equity
- Sector
- Financial Services
- Industry
- Asset Management
- Inception Date
- April 7, 2010
- Domicile
- US
- Fund Type
- ETF
- Fund Issuer
- ProShares
- Asset Class
- Equity
- Sector
- Financial Services
- Industry
- Asset Management
- Inception Date
- April 7, 2010
- Domicile
- US
- Fund Type
- ETF
- Fund Issuer
- ProShares
- Asset Class
- Equity
- Sector
- Financial Services
- Industry
- Asset Management
- Inception Date
- April 7, 2010
- Domicile
- US
About this fund
ProShares Ultra Nasdaq Biotechnology seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Nasdaq Biotechnology Index.
Price Chart
Market price history and trading volume.
Key Facts
Cost, yield, size, and the fund's reference data.
Expense Ratio
1.17%
Yield (12 mo)
0.10%
Fund size
$102.23M
Fund Details
Expense Ratio
1.17%
Dividend Yield (TTM)
0.10%
Assets Under Management
$102.23M
NAV
$116.17 USD
Holdings
274
Average Volume
9.7K
Inception Date
April 7, 2010
Asset Class
Equity
Fund Issuer
ProShares
Domicile
US
ISIN
US74347R2141
CUSIP
74347R214
NAV Currency
USD
Expense Ratio
1.17%
Dividend Yield (TTM)
0.10%
Assets Under Management
$102.23M
NAV
$116.17 USD
Holdings
274
Average Volume
9.7K
Inception Date
April 7, 2010
Asset Class
Equity
Fund Issuer
ProShares
Domicile
US
ISIN
US74347R2141
CUSIP
74347R214
NAV Currency
USD
Distributions · last 12 months
Semi-Annual · 3 payments
| Ex-date | Paid | Amount |
|---|---|---|
| Sep 23, 2026 | Sep 29, 2026 | $0.0413 |
| Mar 25, 2026 | Mar 31, 2026 | $0.0036 |
| Dec 24, 2025 | Dec 31, 2025 | $0.0673 |
| Total, 12 months | $0.11 a share | |
Dividend yield (TTM) 0.10% = $0.11 paid per share in the 12 months to Nov 20, 2026 ÷ the $108.38 price. Past distributions; future payments can differ.
Sectors
How the fund's assets are split across sectors.
- 1Healthcare62.8%
- 2Cash & Others21.5%
- 3Government15.6%
Top sector
Healthcare
Top weight
62.8%
Top 3 weight
100.0%
Holdings
The securities the fund owns, by weight.
Concentration
Top 10 Weight
63.15%
Top 10 Weight
63.15%
Comparables
Funds similar to this one.
Comparable funds
- BKSEBNY Mellon US Small Cap Core Equity ETFEquity0.04%$83M598
- CAMXCambiar Aggressive Value ETFEquity0.59%$69M10
- DIVLMadison Dividend Value ETFEquity0.65%$64M40
- GOPUnusual Whales Subversive Republican Trading ETFEquity0.73%$87M0
- ITDCiShares LifePath Target Date 2035 ETFMulti-Asset0.10%$125M12
- NACPImpact Shares NAACP Minority Empowerment ETFEquity0.49%$74M10
- RSEERareview Systematic Equity ETFEquity3.03%$70M9
- SNTHMRP SynthEquity ETFEquity0.95%$257M0
More ProShares ETFs
- EQQQProshares Ultra Qqq Equal WeightEquity1.12%$4M0
- EQRRProShares - Equities for Rising Rates ETFEquity0.35%$34M52
- ETHDProShares - UltraShort Ether ETFAlternatives0.95%$61M3
- ETHTProShares - Ultra Ether ETFAlternatives0.96%$188M2
- EUDVProShares - MSCI Europe Dividend Growers ETFEquity0.55%$9M47
- EUMProShares Short MSCI Emerging MarketsEquity1.75%$18M9
- EUOProShares UltraShort EuroAlternatives0.95%$39M3
- EWVProShares UltraShort MSCI JapanEquity2.28%$5M5
- EZJProShares Ultra MSCI JapanEquity2.46%$9M9
- FBProShares S&P 500 Dynamic Buffer ETFEquity0.58%$4M0
- FXPProShares UltraShort FTSE China 50Equity2.36%$5M11
- GLLProShares UltraShort GoldCommodities0.95%$89M5
Fund Holders
Institutions that own shares of this fund.
News
Latest headlines and market coverage.
About this section
Latest headlines and company announcements for this company. Press releases and market coverage, newest first.
